Study: 2 stents have equal risk - The Boston Globe: "Study: 2 stents have equal risk
By Bloomberg News October 23, 2006
WASHINGTON -- Boston Scientific Corp. said its Taxus drug-coated heart stents were no more likely than Johnson & Johnson's similar devices to cause blood clots after a year of use.
Article Tools
Printer friendly
E-mail to a friend
Business RSS feed
Available RSS feeds
Most e-mailed
Reprints & Licensing
Save this article
powered by Del.icio.us
More:
Business section
Latest business news
Globe front page
Boston.com
Sign up for: Globe Headlines e-mail Breaking News Alerts The Boston Scientific-funded study, released at a medical meeting yesterday, reinforced the Natick company's assertion that Taxus and J&J's top-selling Cypher device carry equal risk of causing blood clots, which can cause heart attacks and strokes. J&J has said its product is less likely after a year to cause clotting."